R.H. Bluestein & Co’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $578K | Sell |
7,600
-500
| -6% | -$41.4K | 0.04% | 131 |
|
|
2022
Q2 | $685K | Sell |
8,100
-2,000
| -20% | -$175K | 0.04% | 134 |
|
|
2022
Q1 | $886K | Hold |
10,100
| – | – | 0.04% | 118 |
|
|
2021
Q4 | $883K | Hold |
10,100
| – | – | 0.03% | 119 |
|
|
2021
Q3 | $826K | Hold |
10,100
| – | – | 0.03% | 138 |
|
|
2021
Q2 | $922K | Hold |
10,100
| – | – | 0.04% | 134 |
|
|
2021
Q1 | $863K | Hold |
10,100
| – | – | 0.04% | 121 |
|
|
2020
Q4 | $954K | Hold |
10,100
| – | – | 0.04% | 105 |
|
|
2020
Q3 | $878K | Hold |
10,100
| – | – | 0.04% | 104 |
|
|
2020
Q2 | $882K | Sell |
10,100
-100
| -1% | -$8.63K | 0.05% | 99 |
|
|
2020
Q1 | $841K | Buy |
10,200
+40
| +0.4% | +$3.57K | 0.07% | 84 |
|
|
2019
Q4 | $962K | Sell |
10,160
-160
| -2% | -$14.4K | 0.05% | 82 |
|
|
2019
Q3 | $897K | Hold |
10,320
| – | – | 0.05% | 77 |
|
|
2019
Q2 | $942K | Sell |
10,320
-952
| -8% | -$80.6K | 0.05% | 73 |
|
|
2019
Q1 | $971K | Hold |
11,272
| – | – | 0.05% | 72 |
|
|
2018
Q4 | $867K | Sell |
11,272
-2,343
| -17% | -$182K | 0.07% | 58 |
|
|
2018
Q3 | $1.05M | Hold |
13,615
| – | – | 0.05% | 79 |
|
|
2018
Q2 | $922K | Sell |
13,615
-1,563
| -10% | -$108K | 0.05% | 82 |
|
|
2018
Q1 | $1.1M | Sell |
15,178
-1,680
| -10% | -$128K | 0.06% | 83 |
|
|
2017
Q4 | $1.27M | Buy |
16,858
+6
| +0% | +$453 | 0.07% | 65 |
|
|
2017
Q3 | $1.3M | Sell |
16,852
-558
| -3% | -$42.1K | 0.07% | 68 |
|
|
2017
Q2 | $1.3M | Hold |
17,410
| – | – | 0.08% | 65 |
|
|
2017
Q1 | $1.16M | Buy |
17,410
+558
| +3% | +$37.2K | 0.07% | 67 |
|
|
2016
Q4 | $1.1M | Sell |
16,852
-17
| -0.1% | -$1.1K | 0.07% | 64 |
|
|
2016
Q3 | $1.19M | Buy |
16,869
+17
| +0.1% | +$1.24K | 0.08% | 55 |
|
|
2016
Q2 | $1.25M | Sell |
16,852
-111
| -0.7% | -$7.67K | 0.1% | 46 |
|
|
2016
Q1 | $1.1M | Hold |
16,963
| – | – | 0.08% | 65 |
|
|
2015
Q4 | $1.31M | Hold |
16,963
| – | – | 0.08% | 64 |
|
|
2015
Q3 | $1.4M | Sell |
16,963
-112
| -0.7% | -$9.97K | 0.1% | 60 |
|
|
2015
Q2 | $1.5M | Hold |
17,075
| – | – | 0.09% | 66 |
|
|
2015
Q1 | $1.51M | Sell |
17,075
-120
| -0.7% | -$10.6K | 0.09% | 72 |
|
|
2014
Q4 | $1.43M | Hold |
17,195
| – | – | 0.09% | 79 |
|
|
2014
Q3 | $1.45M | Sell |
17,195
-213
| -1% | -$17.2K | 0.09% | 81 |
|
|
2014
Q2 | $1.41M | Buy |
17,408
+361
| +2% | +$28.4K | 0.08% | 81 |
|
|
2014
Q1 | $1.3M | Hold |
17,047
| – | – | 0.09% | 90 |
|
|
2013
Q4 | $1.23M | Sell |
17,047
-5,385
| -24% | -$374K | 0.08% | 91 |
|
|
2013
Q3 | $1.54M | Hold |
22,432
| – | – | 0.11% | 77 |
|
|
2013
Q2 | $1.42M | Buy |
+22,432
| New | +$1.46M | 0.12% | 71 |
|
Other funds holding NVS
R.H. Bluestein & Co's NVS Position: Q3 2022 in Review
R.H. Bluestein & Co reduced its Novartis (NVS) stake by 6.2% in Q3 2022, selling an estimated $41.4K and leaving 7,600 shares worth $578K. The position accounts for 0.04% of the portfolio, ranked #131.
R.H. Bluestein & Co first reported a position in NVS in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.54M in Q3 2013. 1,088 funds tracked by Wall St. Rank hold NVS as of Q3 2022.
- R.H. Bluestein & Co held 7,600 shares of Novartis worth $578K as of Q3 2022.
- R.H. Bluestein & Co sold 500 Novartis shares in Q3 2022, an estimated $41.4K.
- Novartis made up 0.04% of R.H. Bluestein & Co's portfolio in Q3 2022, its #131 holding.
- R.H. Bluestein & Co first reported a position in Novartis in Q2 2013 and has held it in 38 quarters since.
- R.H. Bluestein & Co's Novartis position peaked at $1.54M in Q3 2013.
- 1,088 funds tracked by Wall St. Rank held Novartis as of Q3 2022.
Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.